Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism IKK complex inhibitors(IκB kinase complex inhibitors), NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H32O3 |
InChIKeyDCWLGJGSVWTHNX-RTBURBONSA-N |
CAS Registry1204658-93-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 01 Jan 2010 |